Omega Therapeutics Inc (OMGA)
1.14
+0.08
(+8.06%)
USD |
NASDAQ |
Nov 05, 16:00
1.15
+0.01
(+0.88%)
After-Hours: 18:43
Omega Therapeutics Enterprise Value: 29.25M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 29.25M |
| November 01, 2024 | 32.28M |
| October 31, 2024 | 35.04M |
| October 30, 2024 | 41.10M |
| October 29, 2024 | 39.45M |
| October 28, 2024 | 41.10M |
| October 25, 2024 | 47.72M |
| October 24, 2024 | 51.03M |
| October 23, 2024 | 44.96M |
| October 22, 2024 | 47.72M |
| October 21, 2024 | 30.07M |
| October 18, 2024 | 29.52M |
| October 17, 2024 | 28.42M |
| October 16, 2024 | 20.96M |
| October 15, 2024 | 20.37M |
| October 14, 2024 | 23.54M |
| October 11, 2024 | 24.01M |
| October 10, 2024 | 25.57M |
| October 09, 2024 | 30.07M |
| October 08, 2024 | 30.07M |
| October 07, 2024 | 30.07M |
| October 04, 2024 | 32.83M |
| October 03, 2024 | 33.93M |
| October 02, 2024 | 31.18M |
| October 01, 2024 | 37.24M |
| Date | Value |
|---|---|
| September 30, 2024 | 38.35M |
| September 27, 2024 | 43.86M |
| September 26, 2024 | 40.55M |
| September 25, 2024 | 40.55M |
| September 24, 2024 | 43.86M |
| September 23, 2024 | 44.41M |
| September 20, 2024 | 46.62M |
| September 19, 2024 | 49.38M |
| September 18, 2024 | 49.93M |
| September 17, 2024 | 46.07M |
| September 16, 2024 | 44.41M |
| September 13, 2024 | 44.41M |
| September 12, 2024 | 39.45M |
| September 11, 2024 | 40.00M |
| September 10, 2024 | 40.00M |
| September 09, 2024 | 38.90M |
| September 06, 2024 | 38.35M |
| September 05, 2024 | 46.07M |
| September 04, 2024 | 47.17M |
| September 03, 2024 | 46.62M |
| August 30, 2024 | 52.13M |
| August 29, 2024 | 51.58M |
| August 28, 2024 | 51.03M |
| August 27, 2024 | 52.13M |
| August 26, 2024 | 54.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-84.74M
Minimum
Jun 01 2022
1.181B
Maximum
Oct 29 2021
213.57M
Average
133.83M
Median
Sep 09 2022
Enterprise Value Benchmarks
| Moderna Inc | 12.09B |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.30M |
| Revenue (Quarterly) | 2.134M |
| Total Expenses (Quarterly) | 18.71M |
| EPS Diluted (Quarterly) | -0.30 |
| Profit Margin (Quarterly) | -764.1% |
| Earnings Yield | -124.6% |
| Normalized Earnings Yield | -124.56 |